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Relation of Inﬂammatory Status to Reverse Remodeling in Patients
Undergoing Cardiac Resynchronization Therapy
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Jingfeng Wang
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
OBJECTIVES Cardiac resynchronization therapy (CRT) improves
heart function and reduces all-cause mortality in patients with
chronic heart failure (CHF). However, there are still about one third
patients, who fulﬁlled the indications of guidelines, unrespond to
CRT. The inﬂammatory injury is the major reason for CHF which could
lead to myocardial damage and remodeling. High sensitivity C reac-
tive protein (hs-CRP), as a marker of inﬂammation, would change
even with minor inﬂammatory reaction, and is an independent
predictor for adverse prognosis in CHF. The aim of this study is to
better clarify the effects of CRT on inﬂammatory status by evaluating
hs-CRP and left ventricular remodeling in patients with CHF who
underwent CRT.
METHODS A total of 92 patients who underwent CRT and followed up
regularly were enrolled in this study (since September 2006 to October
2014). Clinical, biochemical and echocardiographic information were
recorded before and after 6 months of CRT. CRT response was deﬁned
as the reduction of end-systolic left ventricular volume(LVESV)
more than 15%. Moreover, we compared left ventricular ejection
fraction, NYHA heart function classiﬁcation, left ventricular end-sys-
tolic and end-diastolic volume and serum hs-CRP before CRT and at
follow-up. Spearman rank analysis was used to assess the correlation
between the changes of serum hs-CRP and end-systolic left ventric-
ular volume. Logistic regression analysis was performed to investigate
associations of response category with baseline hs-CRP and other
clinical indexes.
RESULTS After CRT implantation, left ventricular ejection fraction
signiﬁcantly increased (28.575.30 % vs. 40.0814.91%, P<0.05), and
NYHA heart function classiﬁcation changed (2.750.76 vs. 2.00.33,
P<0.05). After 6 months, there were 51(55.4%) CRT responders, in
which 38 cases with LVESV decreased >30%; and 41(44.6%) CRT
nonresponders, in which 20 cases with LVESV increased. Compared
with CRT nonresponders, there were more patients with complete
left bundle branch block (63.7% vs. 41.4%, P<0.05), decreased
hs-CRP [2.51(1.15-4.35)mg/L vs. 3.76(1.48-7.29), P¼0.049] and intra-
ventricular mechanical dyssynchrony (P<0.05) in CRT responders.
But there were no signiﬁcant differences in other clinical, biochemical
and echocardiographic indexes (P>0.05). After CRT, hs-CRP signiﬁ-
cant decreased, especially in CRT responders[0.4 (0-1.78)mg/L vs.1.5
(0.33-3.35)mg/L, P<0.05]. The changes of hs-CRP correlated with the
reduction in LVESV at follow-up (r¼0.426; P<0.01). In Logistic
regression analysis, CRT response was associated with decreased
baseline hs-CRP (OR 0.764, P¼0.010, 95% CI 0.622-0.938).
CONCLUSIONS The reduction of inﬂammatory status seems to be linked
with reverse remodeling in patients with HF who underwent CRT.
Baseline hs-CRP predicted LVEF response in CRT–treated patients.
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Study on the correlation of asymmetric dimethylarginine and degree of
heart failure
Cuiping Zhao
The ﬁrst hospital of harerbin medical university
OBJECTIVES To evaluate the correlation of the level of ADMA in pa-
tients with congestive heart failure and the degree of heart failure.
METHODS Choose 45 patients with heart failure who reach the stan-
dard of Framingham admitted in the ﬁrst hospital afﬁliated Harbin
medical university between 2011.03-3.03, Among them ischemic car-
diomyopathy group 25 cases, idiopathic dilated cardiomyopathy
group 20 cases and control group 30 cases. Acquired venous blood 5
mL from all the patients in the second day of admission after fasting.
The plasms ADMA were measured by high performance liquid chro-
matography mass spectrometry. Left ventricular ejection fraction
(LVEF) were measured by two-dimensional echocardiography.
Compared serum levels of ADMA in the three groups and estimated
the correlation serum levels of ADMA with their LVEF.
RESULTS We found that ADMA was signiﬁcantly elevated in patients
with heart failure compared to normal control (p <0.001 for both),
There was no difference between ischemic and idiopathic groups in
ADMA (p>0.05), there was an inverse correlation between EF and
serum ADMA level (p< 0.01).CONCLUSIONS ADMA was signiﬁcantly elevated in patients with
heart failure and there was an inverse correlation between EF and
serum ADMA level. There was no correlation between ADMA and
etiology-speciﬁc heart failure.GW26-e2250
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OBJECTIVES Hypothyroidism is a risk factor of heart failure (HF) in
the general population. However, the relationship between hypothy-
roidism and clinical outcomes in patients with established HF is still
inconclusive.
METHODS We conducted a systematic review and meta-analysis to
clarify the association of hypothyroidism and all-cause mortality as
well as cardiac death and/or hospitalization in patients with HF. We
searched MEDLINE via PubMed, EMBASE and Scopus databases for
studies of hypothyroidism and clinical outcomes in patients with HF
published up to the end of Jan 2015. Random-effects models were
used to estimate summary relative risk (RR) statistics.
RESULTS We included 13 articles that reported RR estimates and 95%
conﬁdence intervals (95% CIs) for hypothyroidism with outcomes in
patients with HF. For the association of hypothyroidism with all-cause
mortality and with cardiac death and/or hospitalization, the pooled
RR was 1.44 (95% CI 1.29-1.61) and 1.37 (95% CI: 1.22-1.55), respec-
tively. However, the association disappeared on adjustment for
B-type natriuretic protein level (RR 1.17, 95% CI: 0.90-1.52) and
in studies of patients with mean age < 65 years (RR 1.23, 95% CI: 0.88-
1.76).
CONCLUSIONS We found hypothyroidism associated with increased
all-cause mortality as well as cardiac death and/or hospitalization in
patients with HF. Further diagnostic and therapeutic procedures for
hypothyroidism may be needed for patients with HF.GW26-e3912
Clinical analysis of inhaled furosemide relieving dyspnea in patients with
chronic heart failure
Cong Qin, Yang Zheng
The ﬁrst hospital of jilin university
OBJECTIVES 1. To observe the efﬁcacy of inhaled furosemide relieve
dyspnea in patients with chronic heart failure, correct hypoxemia;
2. To preliminary evaluate the the safety of inhaled furosemide
when applied to the treatment of chronic heart failure patients.
METHODS The study enrolled 60 patients with heart failure, recorded
the subjects’ breathing rate, heart rate, mean arterial pressure, and
plasma N-terminal brain natriuretic peptide (NT-pro BNP), arterial
blood gas analysis (including pH, PaCO2, PaO2, HCO3- and SaO2). In
addition, subjects were asked to evaluate their degree of dyspnea (0 ¼
no dyspnea, 10 ¼ most severe degree of dyspnea). Arterial blood gas
was collected through the radial artery or femoral artery. In this ran-
domized, single blind, placebo controlled trial, subjects were divided
into a control treatment group and the control group, after conven-
tional treatment in both groups were 4ml inhaled furosemide (20mg /
2ml) once a day, or 4ml saline, each once a day. Recording respiratory
rate, arterial blood gas analysis, patients were asked to evaluate their
degree of difﬁculty breathing again; NT-pro BNP was collected in the
ﬁfth day after the treatment.
RESULTS 1. There were signiﬁcant changes in the respiratory rate of
the two groups (P <0.05) after the ﬁrst day of administration within
one hour change. There were signiﬁcant changes in respiratory rate in
both groups at the end of the ﬁfth day of administration (P <0.05).
There were signiﬁcant changes in dyspnea score after the ﬁrst day of
administration within one hour in both groups (P <0.05). There were
signiﬁcant changes in dyspnea score at the end of the ﬁfth day of
administration in both groups (P <0.05), but There were no signiﬁcant
changes between two groups (P >0.05).
2. There were no signiﬁcant changes in PH, PaCO2, SaO2 after the
treatment in experimental group (P>0.05), There were signiﬁcant
changes in PaO2, NT-pro BNP, (P<0.05).
